Preparing abrocitinib for treating moderate-to-severe atopic dermatitis, comprises reacting methylamino cyclobutane compound with acid, reacting acid salt of compound with base, reacting protected 7H-pyrrolo[2,3-d]pyrimidine compound with propane sulfonyl halide, and converting obtained compound
2023-09-14
专利权人METROCHEM API PVT LTD (METR-Non-standard)
申请日期2023-09-14
专利号IN202341062066-A
成果简介NOVELTY - Preparing abrocitinib (I) comprises: (a) reacting methylamino cyclobutane compound (II) with an acid to obtain corresponding acid salt of compound (III'); (b) reacting the acid salt of compound (III') with a suitable base to obtain protected 7H-pyrrolo[2,3-d]pyrimidine compound (III); (c) reacting the compound (III) with propane sulfonyl halide to obtain amino-protected abrocitinib compound (IV); and (d) converting the compound (IV) into abrocitinib (I). USE - Method for preparing abrocitinib for treating moderate-to-severe atopic dermatitis. No biological data given. ADVANTAGE - The method provides abrocitinib (I) with purity of more than 99% by HPLC, and high yield in cost-effective manner. DETAILED DESCRIPTION - Preparing Abrocitinib of formula (I) comprises: (a) reacting methylamino cyclobutane compound of formula (II) with an acid to obtain corresponding acid salt of compound of formula (III'); (b) reacting the acid salt of compound (III') with a suitable base to obtain protected 7H-pyrrolo[2,3-d]pyrimidine compound of formula (III); (c) reacting the compound (III) with propane sulfonyl halide to obtain amino-protected abrocitinib compound of formula (IV); and (d) converting the compound (IV) into abrocitinib (I). P1,P2=amine protecting group; and n=1 or 2. INDEPENDENT CLAIMS are included for: a method for preparing compound (III); and amine-protected 7H-pyrrolo[2,3-d]pyrimidine compound of formula (III'a) and tosyl-substituted 7H-pyrrolo[2,3-d]pyrimidine compound of formula (III'b).
IPC 分类号A61K-031/519 ; C07D-487/04
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/20407
专题中国科学院新疆生态与地理研究所
作者单位
METROCHEM API PVT LTD (METR-Non-standard)
推荐引用方式
GB/T 7714
BIJJULA R V K,SOMISETTI R N,NANDEPU H,et al. Preparing abrocitinib for treating moderate-to-severe atopic dermatitis, comprises reacting methylamino cyclobutane compound with acid, reacting acid salt of compound with base, reacting protected 7H-pyrrolo[2,3-d]pyrimidine compound with propane sulfonyl halide, and converting obtained compound. IN202341062066-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。